PREVENAR 20

This brand name is authorized in Israel.

Active ingredients

The drug PREVENAR 20 contains a combination of these active pharmaceutical ingredients (APIs):

1	Pneumococcus antigen, serotype 1 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
2	Pneumococcus antigen, serotype 3 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
3	Pneumococcus antigen, serotype 4 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
4	Pneumococcus antigen, serotype 5 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
5	Pneumococcus antigen, serotype 6A UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
6	Pneumococcus antigen, serotype 6B UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
7	Pneumococcus antigen, serotype 7F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
8	Pneumococcus antigen, serotype 8 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
9	Pneumococcus antigen, serotype 9V UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
10	Pneumococcus antigen, serotype 10A UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
11	Pneumococcus antigen, serotype 11A UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
12	Pneumococcus antigen, serotype 12F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
13	Pneumococcus antigen, serotype 14 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
14	Pneumococcus antigen, serotype 15b UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
15	Pneumococcus antigen, serotype 18C UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
16	Pneumococcus antigen, serotype 19A UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
17	Pneumococcus antigen, serotype 19F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
18	Pneumococcus antigen, serotype 22F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
19	Pneumococcus antigen, serotype 23F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
20	Pneumococcus antigen, serotype 33F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07AL02	Pneumococcus, purified polysaccharides antigen conjugated	J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AL Pneumococcal vaccines
Discover more medicines within J07AL02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
IL	מִשְׂרַד הַבְּרִיאוּת	9324